| Title : Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Exhibits Antioxidant Mechanism for Abrogation of Cyclophosphamide-Induced Cardiac Damage and Oxidative Hepatorenal Toxicity in Rats - Famurewa_2022_Drug.Res.(Stuttg)__ |
| Author(s) : Famurewa AC , Aja PM , Medewase JO , Abi I , Ogbonna OC , Ofor CC , Nwonuma CO , Asogwa NT , Erejuwa OO |
| Ref : Drug Res (Stuttg) , : , 2022 |
| Abstract : Famurewa_2022_Drug.Res.(Stuttg)__ |
| ESTHER : Famurewa_2022_Drug.Res.(Stuttg)__ |
| PubMedSearch : Famurewa_2022_Drug.Res.(Stuttg)__ |
| PubMedID: 35772725 |
Famurewa AC, Aja PM, Medewase JO, Abi I, Ogbonna OC, Ofor CC, Nwonuma CO, Asogwa NT, Erejuwa OO (2022)
Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Exhibits Antioxidant Mechanism for Abrogation of Cyclophosphamide-Induced Cardiac Damage and Oxidative Hepatorenal Toxicity in Rats
Drug Res (Stuttg)
:
Famurewa AC, Aja PM, Medewase JO, Abi I, Ogbonna OC, Ofor CC, Nwonuma CO, Asogwa NT, Erejuwa OO (2022)
Drug Res (Stuttg)
: